In July, I wrote about how Julia Browning was getting on three months after undergoing Hematopoietic Stem Cell Treatment (HSCT) with Dr. Denis Fedorenko at the A.A. Maximov center in Moscow.
She was doing well, as you can see here.
Now, as […]
Close similarities between Ocrevus (ocreluzimab), currently nearing approval as a treatment for MS, and Rituxan (rituximab) are causing criticism of drug manufacturer Genentech. It faces allegations of profiteering at the expense of MS patients.
The US patent for Rituximab, which has […]
Regular readers of this column will know that I am convinced about the efficacy, reliability, and safety of Hematopoietic Stem Cell Transplantation (HSCT) as a treatment for MS. In fact, a few weeks ago, you learned through this column that my […]Read More
People living in the UK could get faster access, through the country’s National Health Service (NHS), to what are described as ‘innovative’ new treatments following recommendations set out this week in the government’s Accelerated Access Review report, led by an […]Read More
Wheelchairs, scooters and I have a love/hate relationship. Not hate the actual chair, just the need to use one, hate the fact that my mobility is so badly affected by multiple sclerosis that walking, with a walking aid, any further […]Read More
A woman who says her life was made miserable by fatigue caused by multiple sclerosis, claims she is on the road to recovery because she has taken control of her body and is using a combination of hormones and diet.
A damning report looking at workplace discrimination states that 24% of people with MS say their employer has treated them badly as a result of their condition, while 20% say their colleagues have.
And, of the people who say they have […]
Unbelievable, grossly inconsiderate and just plain barmy.
Why UK mental health charity Mind would agree to the one-year secondment of one of its senior managers to the government’s tainted Department of Work and Pensions is as incomprehensible as it is stupid.
A call is being made for a change to improve access to medications to treat multiple sclerosis.
American National MS Society president and CEO Cyndi Zagieboylo said: “It is time for change. People with chronic illnesses need to have confidence that they’ll […]
Proposed changes to the UK’s drug approval process should be the subject of an honest debate according the country’s Multiple Sclerosis Society.
The changes will mean the National Health Service (NHS) in England will assess how much it can afford to […]